NCT03404674View on ClinicalTrials.gov

Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 16, 2018

Primary Completion Date

March 26, 2019

Study Completion Date

March 26, 2019

Conditions
Diarrhea
Interventions
BIOLOGICAL

CssBA

Recombinant enterotoxigenic Escherichia coli (ETEC) surface antigen 6 containing modified structural subunits A and B

BIOLOGICAL

dmLT

Escherichia coli double mutant heat-labile toxin with mutations at amino acids 192 and 211

Trial Locations (1)

20910

Walter Reed Army Institute of Research Clinical Trial Center, Silver Spring

Sponsors
All Listed Sponsors
collaborator

Naval Medical Research Center

FED

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

PATH

OTHER

NCT03404674 - Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC) | Biotech Hunter | Biotech Hunter